| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |